ATAI: Atai Life Sciences N.V. Stock

by  •  • Comments Off on ATAI: Atai Life Sciences N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 181.22
Enterprise Value ($M) 181.09
Book Value ($M) 168.53
Book Value / Share 1.00
Price / Book 1.08
NCAV ($M) 70.66
NCAV / Share 0.42
Price / NCAV 2.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 6.02
Current Ratio 6.02

Balance Sheet (mrq) ($M)
Current Assets 117.91
Assets 215.78
Liabilities 47.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Apeiron Investment Group Ltd. 20.10 3.72

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-11 153,313 468,636 32.71
2024-10-10 204,945 580,473 35.31
2024-10-09 139,619 450,059 31.02
2024-10-08 112,620 276,869 40.68

(click for more detail)

Similar Companies
AQST – Aquestive Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc. ATXS – Astria Therapeutics, Inc.
AUPH – Aurinia Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io